In the age of fast fixes, some beauty treatments are worth the wait—and the patience and consistency required.

Subjects receiving the therapy demonstrated clinically meaningful enhancements in physical and muscle function.

Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that its development candidate LPCN ...

“By looking at someone’s teeth, you can tell if they don’t floss just by examining your gums,” said Brittany Glauz, a ...

Satellos Bioscience Inc. ("Satellos" or the "Company"), a biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today ...

Anglo-Swedish pharma major AstraZeneca reports that it will have a historic presence at this year’s American Society of ...

AnnJi Pharmaceutical Co., Ltd., a clinical-stage Taiwanese biotechnology company focused on addressing unmet medical needs in dermatology, neurology, and rare diseases, today announced positive ...

Bell's palsy, a nerve condition that causes sudden facial paralysis on one side, affecting up to 30,000 Americans yearly.

He is accused of opening fire, striking Yaron Lischinsky, 28, and Sarah Milgrim, 26, cut down in the street as they left the ...

Max Farmer was born healthy but then diagnosed with a rare and genetic condition that causes progressive muscle wasting when ...

Orionis Biosciences Inc. is sticking with Genentech Inc. in a second deal to discover small-molecule monovalent glue therapies for treating cancer. Privately held Orionis is getting $105 million up ...

BridgeBio Pharma, Inc.'s stock soars on Attruby's launch and licensing deals. Click for more on BBIO growth, competition, and ...